Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-022639
Filing Date
2020-08-17
Accepted
2020-08-17 21:32:43
Documents
1
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8303
  Complete submission text file 0000899243-20-022639.txt   9656
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
ROMP CHARLES R (Reporting) CIK: 0001809717 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 201111588